Position in GILD
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$248,258
-$27,555 QoQ
Shares Held
1,965
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,791
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROCKLAND TRUST CO holds $129,433,318 across 10 Drug Manufacturers - General names. GILD ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
490,049 | $62,971,296 | |
| 2 | JNJ |
Johnson & Johnson
|
78,477 | $19,930,803 | |
| 3 | LLY |
ELI LILLY & Co
|
16,303 | $19,554,308 | |
| 4 | PFE |
Pfizer Inc
|
430,196 | $10,359,119 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
146,933 | $8,466,278 | |
| 6 | ABBV |
AbbVie Inc.
|
25,770 | $6,484,762 | |
| 7 | GSK |
GSK plc
|
16,672 | $873,946 | |
| 8 | AMGN |
Amgen Inc
|
778 | $281,729 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,258 | 1,965 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $275,813 | 1,979 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $230,751 | 1,880 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $207,903 | 1,873 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $206,883 | 1,866 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $211,886 | 1,891 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $440,604 | 4,770 | Shares | Defined | 2025-01-14 | |
| 2024-09-30 | $414,588 | 4,945 | Shares | Defined | 2024-10-03 | |
| 2024-06-30 | $341,539 | 4,978 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $330,137 | 4,507 | Shares | Defined | 2024-04-11 | |
| 2023-12-31 | $370,700 | 4,576 | Shares | Defined | 2024-01-11 | |
| 2023-09-30 | $345,473 | 4,610 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $355,292 | 4,610 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $382,491 | 4,610 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $423,154 | 4,929 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $378,221 | 6,131 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $378,956 | 6,131 | Shares | Defined | 2022-07-13 | |
| 2022-03-31 | $364,487 | 6,131 | Shares | Defined | 2022-04-18 | |
| 2021-12-31 | $369,221 | 5,085 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $320,611 | 4,590 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $298,852 | 4,340 | Shares | Defined | 2021-07-21 | |
| 2021-03-31 | $231,504 | 3,582 | Shares | Defined | 2021-04-22 | |
| 2020-12-31 | $213,872 | 3,671 | Shares | Defined | 2021-01-04 | |
| 2020-09-30 | $239,300 | 3,787 | Shares | Defined | 2020-10-08 | |
| 2020-06-30 | $288,525 | 3,750 | Shares | Defined | 2020-07-09 | |
| 2020-03-31 | $284,088 | 3,800 | Shares | Defined | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||